mortality/aging
• 10% of mutants do not survive past 4 weeks of age and by 8 months of age, viability it reduced to 50%
|
growth/size/body
• reduced body weight compared to wild-type and Sspn single homozygotes
|
muscle
• quadriceps muscles show severely diminished levels of laminin and sarcolemma damage
|
• quadriceps muscle weights less than in either single homozygote
|
• quadriceps muscles at 4.5 months of age exhibit sarcolemma damage as indicated by Evan's blue dye accumulation
|
• mutants exhibit myopathy at 4.5 months of age, with centrally placed nuclei in skeletal muscles indicating muscle regeneration
|
• mutants exhibit a greater increase in interstitial connective tissue between myofibers of the diaphragm compared to Itga7 single homozygotes
• mutants exhibit an increase in collagen deposition in the diaphragm and widespread fibrosis and adiposity at 4.5 months of age
|
• diaphragms and quadriceps muscles exhibit greater numbers of small myofibers (more than 2-fold increase) and fewer larger fibers
|
• reduced wet muscle mass compared to wild-type and Sspn single homozygotes
|
• widespread fibrosis and adiposity in the diaphragm at 4.5 months of age and by 9 months of age, diaphragms show significant fibrotic collagen deposition and fat replacement
|
• diaphragms exhibit a 51% reduction in specific muscle force values compared with wild-type
|
• increase in myofiber regeneration at 4.5 months of age, with a 16-fold increase in regeneration in the diaphragm
|
homeostasis/metabolism
• diaphragms exhibit increased susceptibility to eccentric contraction-induced damage as measured by the percent drop in force
|
skeleton
• severe kyphosis at 4.5 months of age as evidenced by the steep slope of the spine behind the shoulder blades, which is exacerbated at 6 months of age
|
limbs/digits/tail
• quadriceps muscles show severely diminished levels of laminin and sarcolemma damage
|
• quadriceps muscle weights less than in either single homozygote
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Duchenne muscular dystrophy | DOID:11723 |
OMIM:310200 |
J:187752 |